Clinical Trial Update: Reduced HPHC Exposure in Cigarette Smokers Switching to P4M3 Gen. 2.0 Compared to Continuing Smoking, or Smoking Abstinence [NA]

View source ↗

Summary

A completed clinical trial examining reduced exposure to HPHC in cigarette smokers who switch to P4M3 Gen. 2.0 compared with continuing smoking or abstinence fr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nicotine Dependence
• Smoking-related Exposure

Drugs mentioned

• P4M3 Gen. 2.0

Snippet

Sponsor: Philip Morris Products S.A. | Conditions: Nicotine, Vaping | NA | Status: COMPLETED | Results posted: 2024-03-13